FDA Inspection
GREFIGREFI – FDA Inspection, Jun 14, 2021
Record Details
This FDA Inspection record concerns GREFI, with an inspection on June 14, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- GREFI
- Inspection Date
- June 14, 2021
- Product Type
- Biologics
View Company Profile
ID · eb7626ec-a116-45d8-bc40-860396419a66
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1145211
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of GREFI
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 1, 2019 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 5, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 31, 2015 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for GREFI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.